17.07.2013 Views

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Kevin m. miller, mD<br />

Kolokotrones Professor of Clinical Ophthalmology<br />

Chief of the Comprehensive Ophthalmology Division<br />

Member of the <strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong><br />

ReseaRch summaRy<br />

Cataract and Refractive Surgery<br />

Dr. Miller’s research interests are in cataract and<br />

refractive surgery, intraocular lenses, artificial iris<br />

implants, ophthalmic optics, surgical devices, and<br />

surgical outcomes.<br />

Dr. Miller’s clinical practice focuses primarily on refractive<br />

cataract surgery and the surgical correction of<br />

presbyopia and astigmatism with premium technology<br />

intraocular lenses. He developed an astigmatism<br />

management service for treating corneal astigmatism at<br />

the time of cataract surgery that optimizes postoperative<br />

uncorrected visual acuity. He developed a nomogram for<br />

peripheral corneal relaxing incisions and participated in<br />

the clinical trial of the world’s most popular toric intra-<br />

ocular lens. He described a nonparametric multivariate<br />

technique for comparing astigmatism outcomes between<br />

treatment groups. In addition to refractive cataract<br />

surgery, he also performs DSEK, LASIK, and other<br />

cornea-based laser refractive procedures.<br />

Dr. Miller runs several clinical trials of artificial iris<br />

implants to treat congenital and acquired aniridia.<br />

The multicenter Ophtec 311 clinical trial is investigat-<br />

ing a colored iris reconstruction lens. Dr. Miller has an<br />

individual device exemption from the FDA to study<br />

Morcher GmbH artificial iris implants. He is the only<br />

surgeon in the United States who is permitted by the<br />

FDA to implant Morcher devices at this time. He is also<br />

studying a custom artificial iris implant from Dr. Schmidt<br />

Intraocularlinsen, a subsidiary of HumanOptics AG.<br />

All of these devices are showing promising results<br />

in patients who suffer from congenital and acquired<br />

iris defects.<br />

54 Faculty | Miller<br />

Public Service<br />

Course Director, Southern California Cataract Surgery<br />

Course for Residents and Fellows<br />

American Academy of Ophthalmology, Skills Transfer<br />

Course Advisory Committee<br />

American Academy of Ophthalmology/Physician<br />

Consortium for Performance Improvement/National<br />

Committee for Quality Assurance <strong>Eye</strong> Care Work Group,<br />

Surgical Management Subgroup Committee<br />

American Academy of Ophthalmology, <strong>Annual</strong> Meeting<br />

Program Committee, Cataract Subcommittee<br />

Column Editor, American Society of Cataract and<br />

Refractive Surgery, <strong>Eye</strong>World Magazine<br />

American Society of Cataract and Refractive Surgery,<br />

Retina Clinical Committee<br />

World Congress of Ophthalmology 2012 Biannual Meeting<br />

Program Planning Committee, Cataract Section<br />

International Editorial Board, Oftalmologia Em Foco<br />

Faculty of 1000, Post-Publication Peer Review,<br />

Lens Disorders Section<br />

American Society of Cataract and Refractive Surgery Skills<br />

Transfer Subcommittee<br />

Reviewer for many scientific journals<br />

Research Grants<br />

Physical Optics Corp./NIH: Clinical Testing of the<br />

Tracking Adaptive-Optic Scanning Laser Ophthalmoscope,<br />

1/15/11–9/29/11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!